OLK Stock Price, Chart, Stats & News

Olink Holding AB (publ)
Save
3.24B
Market cap
–
Current P/E
–
Forward P/E
OLK chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 58.19% |
Operating margin | -29.39% |
Pretax margin | -23.53% |
Net margin | -18.63% |
Effective tax rate | 20.81% |
ROA | -5.26% |
ROE | -6.93% |
D/E | 0.05x |
Interest coverage ratio | -58.21x |
OLK valuation
P/E | – |
P/S | 19.09x |
P/B | 6.43x |
P/CF | -107.66x |
P/FCF | -63.17x |
P/OCF | -107.66x |
PEG | -1.02x |
EV multiple | -107.98x |
About
Olink Holding AB (publ) offers a comprehensive suite of products and services tailored for life science research institutions, including academic bodies, government entities, biopharmaceutical companies, and biotechnology firms. The company's product lines include Olink Explore, which is designed to aid research in critical areas such as cardiovascular and metabolic health, oncology, neurology, and inflammation. Additionally, it features the Olink Target product line and the Olink Focus product line, the latter providing bespoke solutions for clients who have already pinpointed specific proteins or protein signatures for their studies.
Similar securities
Based on sector and market capitalization
Report issue











